Prof. Dr Alan Ong Han Kiat
Funding in UTAR
  • molecular microbiology of a combined farmed freshwater fish and hydroponic system: toward coupled sustainable fish and food plant production, PMI 2 CONNECT ? RESEARCH CO-OPERATION AWARD, BRITISH COUNCIL, April 2008.
  • thermorstability analysis of the recombinant hn glycoprotein of ndv. (co-researcher), ERPA (IN COLLABORATION WITH UPM), January 2001 - December 2003.
  • development of specific dna markers for species identification, sex typing of birds and hybrid testing., UTARRF, December 2005 - December 2006.
  • basic mechanism and effect of binding transition metal complexes of amino acids & their derivatives to nucleic acids (co-researcher), SAGA, October 2005 - September 2007.
  • molecular characterisation of microbial communities associated with fish larvae culture and live feed in a aquaculture tank system, UTARRF, February 2010 - January 2011.
  • molecular characterization of ammonia-oxidizing bacteria in disused tin-mining ponds located within kampar, perak, malaysia, MTSF, January 2010 - December 2011.
  • microbial dna as predictors of oral cancer: molecular analysis of microbial communities associated with precancerous and cancerous lesions of the oral cavity, UTARRF, March 2011 - February 2012.
  • development and characterisation of prostate cancer cell-derived induced pluripotent stem cell (ipsc) for disease modeling and cancer therapy, UTARRF, July 2011 - June 2012.
  • population level studies of microbial communities associated with precancerous, cancerous and cancer-free conditions of the oral cavity, UTARRF, July 2012 - June 2013.
  • gener atio n and c har ac ter isatio n o f induc ed plur ipo tent stem c ells fr o m a leukemia c ell line, UTARRF, July 2012 - June 2013.
  • identification of breast and prostate cancer stem cell dna marker and evaluation of chemotherapeutic drugs on derived cancer stem cells, MOSTI SCIENCE FUND, January 2012 - December 2013.
  • microbial diversity in raw and processed edible bird's nest in west malaysia, UTARRF, February 2013 - January 2014.
  • development and characterization of spheroids (tumor spheres) and viral mediated reprogrammed cancer cells derived from human oral primary cancer cells, UTARRF, February 2013 - January 2014.
  • molecular population genetics of potential microsatellite markers for souteast asian crocodile tomistoma shchlegelii, BOH PLANTATIONS SDN BHD, February 2013 - January 2015.
  • hypermethylation, mirna and chemotherapeutic drugs profiling of the spheroid derivatives from human breast cancer cell lines., UTARRF, February 2014 - January 2015.
  • profiling of mirnas and microsatellite alterations from human adult mscs bone marrow in relation to aging, prolonged passage and hypoxia, UTARRF, February 2014 - January 2015.
  • identification of areas of occurrence, census and genetic diversity using microsatellite markers of tomistoma schlegelii in peninsular malaysia, UTARRF, August 2015 - July 2016.
  • mirna profiling of the spheroid-enriched cancer stem cells subpopulations via next generation transcriptome sequencing, UTARRF, February 2016 - January 2017.
  • circularrna profiling to elucidate egfr oncogenic signalling and pathway signatures in nsclc, UTARRF, July 2018 - June 2019.
  • generation of mesenchymal stem cell (msc)-like cells from induced pluripotent stem cells (ipscs) and evalaution of its cancer properties, differentiation potential and exosomal effects on cancer cells, UTARRF, August 2020 - July 2021.
  • generation of diffuse large b-cell lymphoma (dlbcl)-derived induced pluripotent stem cell (ipsc) from a dlbcl cell line, UTARRF, December 2020 - December 2021.
  • elucidating the underlining mechanism of covid-19 induced lung damage and the immunomodulatory function of ipsc derived mesenchymal stromal cells (imsc) on lung organoids, MOHE FRGS, October 2023 - September 2026.
Funding not in UTAR
  • profiling of microsatellite alterations from human adult mesenchymal stem cell sources in relation to cell senescence and cell population level variation, UM HIGH IMPACT RESEARCH GRANT (UM-HR), January 2012 - December 2015.
  • development of novel exosomal microrna signature as prognostic biomarkers for breast cancer treatment., MAKNA, July 2023 - June 2026.